Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep-Oct;96(5):630-633.
doi: 10.1016/j.abd.2021.02.007. Epub 2021 Jul 27.

Kaposi's sarcoma: a single-center experience on 38 patients

Joana Cruz Matos Calvão da Silva  1 , José Carlos Cardoso  2 , Ricardo Vieira  2
Affiliations

Kaposi's sarcoma: a single-center experience on 38 patients

Joana Cruz Matos Calvão da Silva et al. An Bras Dermatol. 2021 Sep-Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Fig. 1
Clinical presentation of Kaposi’s Sarcoma in four patients: (A–C), papulo-nodular, violaceous lesions on the lower extremities (the most common clinical presentation); (D), a small number of violaceous patches in the upper limb and abdomen in an HIV patient.
Figure 2
Fig. 2
Anaplastic variant of Kaposi’s Sarcoma: histological (A-C), and clinical (D), pictures. Dense tumoral proliferation in the dermis (A, Hematoxylin & eosin ×40), mainly composed of epithelioid cells with pleomorphism and frequent mitoses (B, Hematoxylin & eosin ×400). (C), Dissection of collagen bundles by vascular clefts with atypical endothelial cells (Hematoxylin & eosin ×200). (D) Large and infiltrated violaceous plaque with papillomatous areas in the left upper limb.
Figure 3
Fig. 3
PET-CT scan showing the progression of Kaposi’s Sarcoma with metastatic involvement of the liver in a patient with previously known gastrointestinal and pulmonary involvement. This patient later died despite multiple treatments, including doxorubicin, alfa-interferon, paclitaxel, vinorelbine, and radiotherapy.
See this image and copyright information in PMC

References

    1. Lebbe C., Garbe C., Stratigos A.J., Harwood C., Peris K., Del Marmol V. Diagnosis and treatment of Kaposi’s sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC) Eur J Cancer. 2019;114:117–127. - PubMed
    1. Requena C., Alsina M., Morgado-Carrasco D., Cruz J., Sanmartín O., Serra-Guillén C. Kaposi Sarcoma and Cutaneous Angiosarcoma: Guidelines for Diagnosis and Treatment. Actas Dermosifiliogr. 2018;109:878–887. - PubMed
    1. Yazici S., Zorlu O., Bulbul Baskan E., Balaban Adim S., Aydogan K., Saricaoglu H. Retrospective analysis of 91 kaposi’s sarcoma cases: A single-center experience and review of the literature. Dermatology. 2018;234:198–204. - PubMed
    1. Marcoval J., Bonfill-Ortí M., Martínez-Molina L., Valentí-Medina F., Penín R.M., Servitje O. Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin. Clin Exp Dermatol. 2019;44:32–39. - PubMed
    1. Coates S.J., Leslie K.S. What’s new in HIV dermatology? F1000Research. 2019;8:F1000. - PMC - PubMed